Oncogenic activity may be key to carcinoma development

February 2011
Hem/Onc Today;2/25/2011, Vol. 12 Issue 4, p5
The article provides information on a study which found that oncogene-induced senescence may be important to identify the development of carcinoma.


Related Articles

  • Telomerase is not an oncogene. Harley, Calvin B // Oncogene;1/21/2002 Review, Vol. 21 Issue 4, p494 

    In the decade since the telomere hypothesis of cellular aging was proposed, the two essential genes for human telomerase were cloned and characterized, allowing experimental proof of the causal relationships between telomere loss and replicative senescence, and telomerase activation and...

  • Oncogene-Induced Cell Senescence – Halting on the Road to Cancer. Mooi, W. J.; Peeper, D. S. // New England Journal of Medicine;9/7/2006, Vol. 355 Issue 10, p1037 

    The article examines the notion that oncogene-induced senescence is an in vivo mechanism that contributes to protection against cancer. It states that oncogene-induced senescence is triggered by unscheduled signaling within the cell by the protein products of oncogenes and is accompanied by the...

  • The power and the promise of oncogene-induced senescence markers. Collado, Manuel; Serrano, Manuel // Nature Reviews Cancer;Jun2006, Vol. 6 Issue 6, p472 

    Recently, it has been shown that oncogene-induced senescence (OIS) occurs during the early stages of tumorigenesis. Senescent tumour cells are abundant within premalignant neoplastic lesions, whereas they are scarce in malignant tumours. This association of senescence with the premalignant...

  • Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Di Mitri, Diletta; Toso, Alberto; Chen, Jing Jing; Alimonti, Andrea; Sarti, Manuela; Pinton, Sandra; Guccini, Ilaria; Catapano, Carlo; Jost, Tanja Rezzonico; D'Antuono, Rocco; Montani, Erica; Garcia-Escudero, Ramon; Da Silva-Alvarez, Sabela; Collado, Manuel; Eisenberger, Mario; Zhang, Zhe; Grassi, Fabio // Nature;11/6/2014, Vol. 515 Issue 7525, p134 

    Aberrant activation of oncogenes or loss of tumour suppressor genes opposes malignant transformation by triggering a stable arrest in cell growth, which is termed cellular senescence. This process is finely tuned by both cell-autonomous and non-cell-autonomous mechanisms that regulate the entry...

  • Senescence comes of age. Narita, Masashi; Lowe, Scott W. // Nature Medicine;Sep2005, Vol. 11 Issue 9, p920 

    Reports that several studies now show that oncogene-induced cellular senescence can occur in vivo and provides a bona fide barrier to tumorigenesis. Study of senescent cells in several premalignant or benign conditions; Factors which cause senescence; Ability of oncogenic lesions to disable...

  • Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Zhenbang Chen; Trotman, Lloyd C.; Shaffer, David; Hui-Kuan Lin; Dotan, Zohar A.; Niki, Masaru; Koutcher, Jason A.; Scher, Howard I.; Ludwig, Thomas; Gerald, William; Cordon-Cardo, Carlos; Pandolfi, Pier Paolo // Nature;8/4/2005, Vol. 436 Issue 7051, p725 

    Cellular senescence has been theorized to oppose neoplastic transformation triggered by activation of oncogenic pathways in vitro, but the relevance of senescence in vivo has not been established. The PTEN and p53 tumour suppressors are among the most commonly inactivated or mutated genes in...

  • RAS, cellular senescence and transformation. Zhigang Tu; Aird, Katherine M.; Rugang Zhang // Small GTPases;2012, Vol. 3 Issue 3, p163 

    The definition of an oncogene is a gene that actively promotes tumorigenesis. For example, activation of RAS oncogene promotes cell transformation and cancer. Paradoxically, in primary mammalian cells, oncogenic RAS typically triggers cellular senescence, a state of irreversible cell growth...

  • C/EBPβ cooperates with RB:E2F to implement RasV12-induced cellular senescence. Sebastian, Thomas; Malik, Radek; Thomas, Sara; Sage, Julien; Johnson, Peter Frederick // EMBO Journal;9/21/2005, Vol. 24 Issue 18, p3301 

    In primary cells, overexpression of oncogenes such as RasV12 induces premature senescence rather than transformation. Senescence is an irreversible form of G1 arrest that requires the p19ARF/p53 and p16INK4a/pRB pathways and may suppress tumorigenesis in vivo. Here we show that the transcription...

  • New insights into skin stem cell aging and cancer. Ortells, M. Carmen; Keyes, William M. // Biochemical Society Transactions;Jun2014, Vol. 42 Issue 3, p663 

    Adult tissue homoeostasis requires continual replacement of cells that are lost due to normal turnover, injury and disease. However, aging is associated with an overall decline in tissue function and homoeostasis, suggesting that the normal regulatory processes that govern self-renewal and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics